The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
March 2024 — Vol. 1, No. 3
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, March 2024A shortage listing ends. 6 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
QSC declines, for the 21st time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Saudi Arabia declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
What changed at CPC in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Sweden caps dulaglutide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
New Zealand pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new the United Arab Emirates guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The consolidator trading as Meridian Freight Partners closes after 7 years
A proper account of an operation that existed, and of what closing it cost.
Sweden caps dulaglutide prescribing to 7 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at WXT in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A supplier suspends shipping to Norway after 12 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Sweden declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
SURPASS-3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.